文献速递腹部MR

药物性肝损伤MRI特征与损伤类型、严重程度及预后的关联

Identification of MRI features associated with injury type, severity, and prognosis in drug-induced liver injury.
PubMed 文献 · Eur Radiol · 2022-08-18

回顾性分析180例药物性肝损伤患者,识别与损伤类型、严重程度及肝移植/肝相关死亡相关的MRI特征。肝细胞型和混合型损伤中门周水肿比例显著高于胆汁淤积型;肝表面不规则、一过性肝灌注差异和脾大与严重程度独立相关;一过性肝灌注差异和腹水与肝移植/肝相关死亡独立相关,预测模型AUC为0.959。

要点

  • 门周水肿提示肝细胞型或混合型损伤,胆汁淤积型少见。
  • 肝表面不规则、一过性肝灌注差异和脾大提示损伤严重。
  • 一过性肝灌注差异和腹水可预测1年内肝移植或肝相关死亡。

关键影像表现/征象

  • 肝细胞型和混合型损伤中门周水肿比例分别为62.2%和47.8%,显著高于胆汁淤积型的18.2%(p<0.001)。
  • 肝表面不规则、一过性肝灌注差异和脾大与严重程度独立相关。
  • 一过性肝灌注差异和腹水与肝移植/肝相关死亡独立相关。

诊断标准与关键数值

  • 肝表面不规则与严重程度的未调整OR为6.56(95%CI 1.27-22.84)。
  • 一过性肝灌注差异与严重程度的未调整OR为3.27(95%CI 1.14-9.36)。
  • 脾大与严重程度的未调整OR为5.86(95%CI 1.96-17.53)。
  • 一过性肝灌注差异与肝移植/肝相关死亡的未调整OR为8.89(95%CI 1.35-58.43)。
  • 腹水与肝移植/肝相关死亡的未调整OR为64.63(95%CI 6.93-602.40)。

临床应用与阅片要点

  • 阅片时注意门周水肿,辅助区分肝细胞型/混合型与胆汁淤积型损伤。
  • 关注肝表面不规则、一过性肝灌注差异和脾大,提示损伤严重。
  • 发现一过性肝灌注差异或腹水时,应提示临床警惕肝移植/肝相关死亡风险。

局限性

  • 单中心回顾性研究。
  • 肝移植/肝相关死亡事件数较少(8例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To identify magnetic resonance imaging (MRI) features associated with injury type, severity, and liver transplantation (LT)/liver-related death (LRD) in drug-induced liver injury (DILI).

METHODS: The eligible DILI patients (2016 to 2020) who underwent contrast abdominal MRI within 3 months of onset were retrospectively analysed at Beijing Friendship Hospital, Capital Medical University. The MRI features independently associated with severity and prognosis were identified by backwards logistic regression. Unadjusted odds ratios (ORs) and 95% confidence intervals (CIs) are given.

RESULTS: The median age of 180 patients was 55.5 years, with 126 (70.0%) women. The injury types included hepatocellular (135 cases, 75.0%), mixed (23, 12.8%), and cholestatic (22, 12.2%). The proportion of periportal oedema in patients with hepatocellular and mixed injury was significantly higher than that in cholestatic injury (62.2%, 47.8% vs. 18.2%, p < 0.001). For severity, 157 (87.2%) patients had mild to moderate injury, and 23 (12.8%) had severe to fatal/LT. Irregularity of the liver surface (6.56 (95% CI, 1.27-22.84)), transient hepatic attenuation difference (THAD) (3.27 (95% CI, 1.14-9.36)), and splenomegaly (5.86 (95% CI, 1.96-17.53)) were independently associated with severity. Eight (4.4%) patients died/underwent LT. THAD (8.89 (95% CI, 1.35-58.43)), and ascites (64.63 (95% CI, 6.93-602.40)) were independently associated with LT/LRD. The prediction of the new model employing THAD and ascites for LT/LRD within 1 year was 0.959 (95% CI, 0.917-1.000).

CONCLUSIONS: Periportal oedema was associated with the type of injury. Irregularity of the liver surface, THAD, and splenomegaly were associated with severity. THAD and ascites may have potential clinical utility in predicting LT/LRD outcomes within 1 year.

KEY POINTS: • Contrast abdominal magnetic resonance imaging features can help clinicians evaluate the type of injury, severity, and poor prognosis of drug-induced liver injury. • Transient hepatic attenuation difference and ascites have potential clinical utility in the prediction of the poor prognosis of liver transplantation/liver-related death. • The new model predicting poor prognosis has a relatively high sensitivity of 0.875 and a high specificity of 0.919.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Wu, Yang, Wee, et al. Identification of MRI features associated with injury type, severity, and prognosis in drug-induced liver injury. Eur Radiol. 2022. PMID: 35980428. doi:10.1007/s00330-022-09041-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。